MA27868A1 - Peptides pour le traitement du cancer associe au virus du papillome humain (vph) et d'autres tumeurs. - Google Patents

Peptides pour le traitement du cancer associe au virus du papillome humain (vph) et d'autres tumeurs.

Info

Publication number
MA27868A1
MA27868A1 MA27740A MA27740A MA27868A1 MA 27868 A1 MA27868 A1 MA 27868A1 MA 27740 A MA27740 A MA 27740A MA 27740 A MA27740 A MA 27740A MA 27868 A1 MA27868 A1 MA 27868A1
Authority
MA
Morocco
Prior art keywords
peptides
hpv
tumors
treatment
papilloma virus
Prior art date
Application number
MA27740A
Other languages
English (en)
Inventor
Rodriguez Silvio Ernesto Perea
Acosta Osvaldo Reyes
Vispo Nelson Francisc Santiago
Izaguirre Yaquelin Puchades
Rodriguez Ricardo Silva
Soria Alejandro Moro
Savio Alicia Santos
Lopez Luis Javier Gonzalez
Barrios Belkis Gonzalez
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Publication of MA27868A1 publication Critical patent/MA27868A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention se rapporte à des peptides utilisés pour le traitement de tumeurs d'origine épithéliale, et spécifiquement de ceux associés à des types oncogènes du virus du papillome (VPH). L'invention se rapporte également à l'identification de peptides dont la structure permet le blocage du domaine de phosphorilation par la caséine kinase II (CKII) par le biais de l'interaction directe avec ledit site. Dans la présente invention, on travaille sur onze peptides à structure cyclique et séquence d'acides aminés différentes, lesquels inhibent le site de phosphorilation par CKII in vitro, produisent une cytotoxicité dans les cellules de carcinome du col utérin humain transformées par VPH-16 (CaSki) et augmentent par ailleurs la sensibilité desdites cellules à l'action cytostatique de l'interféron (IFN). L'invention se rapporte de plus à l'usage de ces peptides conjugués ou fusionnés avec d'autres peptides et composés chimiques à pénétration intracellulaire et à l'utilisation de molécules mimétiques d'origine peptidique et chimique.
MA27740A 2001-12-20 2004-06-15 Peptides pour le traitement du cancer associe au virus du papillome humain (vph) et d'autres tumeurs. MA27868A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20010309A CU23225A1 (es) 2001-12-20 2001-12-20 PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Publications (1)

Publication Number Publication Date
MA27868A1 true MA27868A1 (fr) 2006-05-02

Family

ID=40091679

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27740A MA27868A1 (fr) 2001-12-20 2004-06-15 Peptides pour le traitement du cancer associe au virus du papillome humain (vph) et d'autres tumeurs.

Country Status (33)

Country Link
US (2) US7374767B2 (fr)
EP (2) EP2383282A1 (fr)
JP (1) JP4056476B2 (fr)
KR (1) KR100642437B1 (fr)
CN (1) CN100368431C (fr)
AR (1) AR037825A1 (fr)
AT (1) ATE520704T1 (fr)
AU (1) AU2002361922B2 (fr)
BR (1) BRPI0215213C1 (fr)
CA (1) CA2471110C (fr)
CR (1) CR7361A (fr)
CU (1) CU23225A1 (fr)
DK (1) DK1491553T3 (fr)
DO (1) DOP2002000548A (fr)
ES (1) ES2371239T3 (fr)
HN (1) HN2002000377A (fr)
HR (1) HRP20040663B1 (fr)
IL (2) IL162633A0 (fr)
IS (1) IS2906B (fr)
MA (1) MA27868A1 (fr)
MX (1) MXPA04005832A (fr)
MY (1) MY133530A (fr)
NO (1) NO333259B1 (fr)
NZ (1) NZ534170A (fr)
PE (1) PE20030861A1 (fr)
PT (1) PT1491553E (fr)
RU (1) RU2290410C2 (fr)
SI (1) SI1491553T1 (fr)
TN (1) TNSN04114A1 (fr)
UA (1) UA81403C2 (fr)
UY (1) UY27602A1 (fr)
WO (1) WO2003054002A1 (fr)
ZA (1) ZA200405514B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES
CU23431B6 (es) * 2005-05-12 2009-10-16 Ct Ingenieria Genetica Biotech Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
GB2433740A (en) * 2005-12-23 2007-07-04 Rapid Biosensor Systems Ltd Detection of tuberculosis infection
CU23511B6 (es) * 2006-02-28 2010-04-13 Biorec B V Combinación farmacéutica para el tratamiento y/o quimiosensibilización de tumores refractarios a drogas anticancerígenas
GB2441131A (en) * 2006-08-24 2008-02-27 Univ Dundee Modulation of binding of CK2a to NDPK
CN100522992C (zh) * 2007-02-12 2009-08-05 中国科学院昆明动物研究所 一种环状小肽ba
EP2133083A4 (fr) * 2007-03-27 2012-02-15 Taiko Pharmaceutical Co Ltd Agent thérapeutique pour une maladie infectieuse cutanée ou des muqueuses
US20110305706A1 (en) 2009-02-23 2011-12-15 Scott Thomas Brady Compositions and Methods for Treating a Disease Mediated by Soluble Oligomeric Amyloid Beta
CA2755245A1 (fr) * 2009-03-13 2010-09-16 Egen, Inc. Compositions et procedes pour l'administration d'arn biologiquement actifs
IL290457B2 (en) 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CU20200103A7 (es) * 2020-12-18 2022-07-08 Ct Ingenieria Genetica Biotecnologia Péptido sintético para la inducción de inmunidad antitumoral y antiviral
CU24766B1 (es) 2021-07-09 2025-08-13 Ct Ingenieria Genetica Biotecnologia Péptidos lineales que inhiben la fosforilación mediada por ck2
CN118370805B (zh) * 2024-04-29 2025-02-14 广州中科佰氏健康产业有限公司 一种抑菌妇科凝胶及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902820A1 (en) 1989-08-07 1991-02-27 Merck & Co Inc Peptide inhibitors of human papilloma virus protein binding¹to retinoblastoma gene proteins
JPH05310784A (ja) * 1991-09-04 1993-11-22 Merck & Co Inc ヒト乳頭腫ウイルスタンパク質と網膜芽細胞腫遺伝子タンパク質との結合のペプチド阻害剤
GB9313556D0 (en) 1993-07-01 1993-08-18 British Tech Group Synthetic peptides of human papillomavirus
US5625031A (en) * 1994-02-08 1997-04-29 Bristol-Myers Squibb Company Peptide inhibitors of the p33cdk2 and p34cdc2 cell cycle regulatory kinases and human papillomavirus E7 oncoprotein
ATE235509T1 (de) * 1998-06-30 2003-04-15 Deutsches Krebsforsch Peptide zur inhibition von hpv e7 proteinen
US6641994B2 (en) * 1999-08-25 2003-11-04 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
CU23225A1 (es) * 2001-12-20 2007-08-30 Ct Ingenieria Genetica Biotech PéPTIDOS PARA EL TRATAMIENTO DEL CáNCER ASOCIADO AL VIRUS PAPILOMA HUMANO (VPH) Y DE OTROS TUMORES EPITELIALES

Also Published As

Publication number Publication date
IL162633A (en) 2011-02-28
AU2002361922B2 (en) 2007-04-05
CR7361A (es) 2005-02-18
UA81403C2 (en) 2008-01-10
SI1491553T1 (sl) 2011-12-30
ZA200405514B (en) 2005-03-30
HRP20040663A2 (en) 2005-08-31
JP2005525090A (ja) 2005-08-25
RU2004122084A (ru) 2005-03-27
CA2471110A1 (fr) 2003-07-03
UY27602A1 (es) 2003-04-30
NZ534170A (en) 2006-08-31
CN1620464A (zh) 2005-05-25
DOP2002000548A (es) 2003-06-30
EP2383282A1 (fr) 2011-11-02
MXPA04005832A (es) 2004-09-13
TNSN04114A1 (en) 2006-06-01
HN2002000377A (es) 2003-04-10
KR100642437B1 (ko) 2006-11-06
IS2906B (is) 2014-11-15
CA2471110C (fr) 2017-01-31
US20060233742A1 (en) 2006-10-19
IL162633A0 (fr) 2005-11-20
WO2003054002A1 (fr) 2003-07-03
IS7320A (is) 2004-06-16
JP4056476B2 (ja) 2008-03-05
HK1068901A1 (en) 2005-05-06
AU2002361922A1 (en) 2003-07-09
BRPI0215213B1 (pt) 2018-09-11
MY133530A (en) 2007-11-30
US7374767B2 (en) 2008-05-20
AR037825A1 (es) 2004-12-09
PT1491553E (pt) 2011-11-25
US20090005294A1 (en) 2009-01-01
NO20043112L (no) 2004-07-20
KR20050002811A (ko) 2005-01-10
BR0215213A (pt) 2004-12-07
EP1491553A1 (fr) 2004-12-29
ES2371239T3 (es) 2011-12-28
DK1491553T3 (da) 2011-12-05
HRP20040663B1 (hr) 2013-05-31
ATE520704T1 (de) 2011-09-15
PE20030861A1 (es) 2003-12-02
CU23225A1 (es) 2007-08-30
NO333259B1 (no) 2013-04-22
EP1491553B1 (fr) 2011-08-17
US7947287B2 (en) 2011-05-24
CN100368431C (zh) 2008-02-13
BRPI0215213C1 (pt) 2021-05-25
RU2290410C2 (ru) 2006-12-27

Similar Documents

Publication Publication Date Title
RU2018100181A (ru) Модифицированный белок интерлейкина-7 и способы его применения
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
EA200401064A1 (ru) Вирусоподобные частицы из вируса папилломы человека
PL363071A1 (pl) Sposoby i kompozycje dla zmniejszenia replikacji HIV-1
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EA200200820A1 (ru) Пептиды, полученные из казеина, и их применение в терапии
WO2003103589A3 (fr) Utilisation d'il-21 dans le traitement du cancer et dans d'autres applications therapeutiques
DE69330988D1 (de) Peptide des menschlichen papillomavirus zur verwendung in zusammensetzungen, die eine menschliche t-zellreaktion induzieren
AU2017385913B2 (en) Pharmaceutical composition comprising F1 and F3 polypeptides, and application thereof in treating HPV infection
CA2699894A1 (fr) Derives de cholesterol d'inhibiteurs de la fusion virale
EA200000144A1 (ru) Направленный цитолиз клеток-мишеней, агенты и композиции, вызывающие цитолиз, и соединения, которые можно использовать для получения этих агентов
US20090005294A1 (en) Peptides for the Treatment of Cancer Associated with the Human Papilloma Virus (HPV) and Other Epithelial Tumors
CN116801908A (zh) 用于降解病毒和宿主蛋白的嵌合缀合物和使用方法
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
CY1106644T1 (el) Ρυθμιστικα/αναδιπλωμενα πεπτιδια της εζρινης
DE69530857D1 (de) Therapeutische quassinoid-zubereitungen mit antineoplastischer, antiviraler und herbistatischer wirkung
DK0579363T3 (da) Behandling af tropisk spastisk parese med peptid T
DE69935414D1 (en) Humanes btrcp protein
WO2001000829A3 (fr) Retrovirus endogene humain present dans le cancer du sein
RU2008152813A (ru) Пептиды с антипролиферативной активностью
CY1112340T1 (el) Πεπτιδια για την θεραπευτικη αγωγη καρκινου που συνδεεται με τον ιο ανθρωπινων θηλωματων (hpv) και αλλων επιθηλιακων ογκων
TH59183B (th) เพพไทด์สำหรับการรักษามะเร็งที่เกี่ยวข้องกับแพพิลโลมาไวรัส (hpv) ของมนุษย์และเนื้องอกของเนื้อเยื่อบุผิวอื่น
WO2001034095A8 (fr) Procede pour traiter des maladies virales et d'autres troubles par la modification de l'expression genique immediate au moyen de l'administration du peptide t